Bronfeld Zeev Insider Trades

Insider Trading History

Track insider trading activity for Bronfeld Zeev. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $196k 100,000 shares
Last Trade
Sep 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 200,000 shares
$1.03
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $470k 240,000 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$888k 240,000 shares
$3.70
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $0 0 shares
Last Trade
Oct 02, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$35.5M 1,509,948 shares
$23.50
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $4.24M 2,162,481 shares
Last Trade
Oct 02, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$7.62M 324,372 shares
$23.50
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $3.6M 1,838,109 shares
Last Trade
Sep 16, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$45M 1,838,109 shares
$24.50
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Director
Holding Value $2.96M 1,509,948 shares
Last Trade
Sep 16, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$210M 8,556,371 shares
$24.50
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
10% owner
Holding Value $19.7M 10,066,319 shares
Last Trade
Aug 13, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$116M 4,400,000 shares
$26.30
$1.96
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
10% owner
Holding Value $21.2M 5,808,517 shares
Last Trade
Sep 27, 2011 Sale (Open Market)Shares sold on the open market or in a private sale.
$98k 350,000 shares
$0.28
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
10% owner
Holding Value $21.2M 5,808,517 shares
Last Trade
Sep 27, 2011 Sale (Open Market)Shares sold on the open market or in a private sale.
$98k 350,000 shares
$0.28
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
10% owner
Holding Value $26.3M 7,213,205 shares
Last Trade
Mar 31, 2011 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$211k 781,250 shares
$0.27
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
10% owner
Holding Value $998k 273,438 shares
Last Trade
Mar 31, 2011 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$73.8k 273,438 shares
$0.27
$3.65
Orchard Therapeutics plc
Orchard Therapeutics plc ORTX
10% owner
Holding Value $242M 14,466,319 shares
Last Trade
Dec 31, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$16.70
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
10% owner
Holding Value $28.4M 14,466,319 shares
Last Trade
Dec 31, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up